Sponsors (56)
The bill would standardize and study fentanyl testing to improve overdose diagnosis and clinician decision-making and potentially reduce waste, but it risks raising privacy concerns, increasing costs for providers/patients, and deterring vulnerable people from seeking emergency care if safeguards are not strong.
Emergency department patients (including people who overdose) would receive clearer, evidence-based fentanyl testing policies that improve diagnosis and enable more tailored clinical care.
Clinicians and hospital systems would get clearer guidance about which substances are included in routine drug tests, improving informed consent and clinical decision-making.
Hospitals, patients, and payers could benefit from a mandated cost–benefit study of fentanyl testing that may identify more cost‑effective testing practices and reduce unnecessary testing expenses.
Low-income individuals and other people at risk of overdose may avoid seeking emergency care if testing guidance is perceived as mandatory or if testing/data use is not clearly protected.
Patients (including those with chronic conditions) could face increased privacy concerns if routine fentanyl testing is implemented without strong confidentiality safeguards.
Hospitals and health systems may incur additional administrative and testing costs if guidance recommends more routine fentanyl testing, which could raise charges for patients and payers.
Based on analysis of 2 sections of legislative text.
Requires HHS to study ED fentanyl testing for overdose patients within 1 year and issue guidance within 6 months after the study on routine testing and clinician notification.
Introduced March 10, 2025 by Ted Lieu · Last progress March 10, 2025
Requires the HHS Secretary to complete a study, within one year of enactment, on emergency department practices and the impacts of fentanyl testing for patients who present with an overdose. The study must examine how often EDs test for fentanyl, costs, benefits and risks to patients, and effects on patient experience including privacy and the patient–physician relationship. Within six months after finishing the study, the Secretary must issue guidance—based on the findings—on whether EDs should routinely implement fentanyl testing for overdose patients, how to inform clinicians about what substances are included in routine tests, and how testing may affect future overdose risk and health outcomes.